THDB(600867.SH)

Company Encyclopedia

THDB

600867.SH

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education.

2.788 T

600867.SHMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update

PharmaceuticalsIndustry

Industry Ranking15/215

Industry medianC

Industry averageC

Score Analysis

Peer Comparison

Criteria
Rating
Profit ScoreA
- ROE18.01%A
- Profit Margin40.64%A
- Gross Margin71.62%A
Growth ScoreA
- Revenue YoY47.05%A
- Net Profit YoY934.27%A
- Total Assets YoY9.31%B
- Net Assets YoY11.16%B
Cash ScoreB
- Cash Flow Margin68.98%C
- OCF YoY47.05%A
Operating ScoreC
- Turnover0.39C
Debt ScoreA
- Gearing Ratio12.27%A

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
东宝实业集团股份有限公司	31.63%	No Change	29/04/2026
天津桢逸股权投资合伙企业(有限合伙)	9.35%	No Change	29/04/2026
阿布达比投资局-自有资金	1.65%	-277.00 K	29/04/2026
香港中央结算有限公司	1.49%	-12.86 M	29/04/2026
杨祖贵	0.97%	No Change	29/04/2026
上海银行股份有限公司-银华中证创新药产业交易型开放式指数证券投资基金	0.92%	3.66 M	29/04/2026
中国银行股份有限公司-招商国证生物医药指数分级证券投资基金	0.89%	24.00 K	29/04/2026
李一奎	0.58%	No Change	29/04/2026
中国银行股份有限公司-广发中证创新药产业交易型开放式指数证券投资基金	0.53%	2.25 M	29/04/2026
通化东宝药业股份有限公司-2025年员工持股计划	0.47%	No Change	29/04/2026